Outcomes of left ventricular assist device implantation in hypercoagulable patients

ConclusionsIn this series, positive laboratory tests for hypercoagulability were common amongst patients undergoing LVAD implantation although few had positive clinical histories. Survival and freedom from thromboembolic complications were comparable to non ‐hypercoagulable patients. Hypercoagulability alone should therefore not serve as a contraindication to LVAD implantation.

Source: Journal of Cardiac Surgery - July 26, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Keith A. Dufendach, Laura Seese, Blaise Stearns, Gavin Hickey, Michael Mathier, Mary Keebler, Shangzhen Chen, Christopher M. Sciortino, Floyd W. Thoma, Arman Kilic Tags: ORIGINAL ARTICLE Source Type: research